Response to Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".
Xiaoli ZhengYanqing LiuQinqin YuHua WangFuqing TanQianying ZhuLingmin YuanHuidi JiangSu ZengLushan YuPublished in: Science translational medicine (2018)